Almstead Neil Gregory bought PTCT
October 3, 2025 · Form 4 insider transaction
Almstead Neil Gregory bought 3,442 shares of PTC Therapeutics, Inc. at $30.86 per share, a transaction worth $106.2K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,442
Price
$30.86
Total value
$106.2K
InsiderAlmstead Neil Gregory
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 3, 2025
Filing dateOctober 7, 2025
Shares owned after104,067
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024; Includes 272 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2025.